Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Novo Nordisk, Inc. Company Profile

04:41 EDT 20th April 2014 | BioPortfolio

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. Headquartered in Denmark, Novo Nordisk employs more than 29,650 employees in 76 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchange in Copenhagen and its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk-us.com.


News Articles [312 Associated News Articles listed on BioPortfolio]

Novo Nordisk-Aktie gehört zur Grundausstattung!

Bagsværd - Die Aktienexperten von "boerse.de-Aktienbrief" nehmen die Novo Nordisk-Aktie (ISIN DK0060102614/ WKN A0M9QL) unter die Lupe. Bis Ende September 2013 habe Novo Nordisk 61,9 Mrd. Dänische ....

NASDAQ OMX Nordic: Derivatives: Adjustment due split in Novo Nordisk (75/13)

The board of Novo Nordisk A/S (Novo Nordisk) has decided on a stock split whereby every one (1) share held will be replaced by five new shares (5:1). The ex-date is January 2, 2014. NASDAQ OMX Deri...

NASDAQ OMX Nordic: Derivatives: New ISIN codes following adjustment in Novo Nordisk (78/13)

NASDAQ OMX Derivatives Markets has carried out a re-calculation of options and futures in Novo Nordisk A/S (Novo Nordisk) due to a split. For details regarding the re-calculation please see exchang...

Novo Nordisk Files for Liraglutide Approval from FDA, EMA

Novo Nordisk announced two separate regulatory submissions for a 3 mg dose of liraglutide, a once-daily human GLP-1 analogue, as an adjunct to a reduced-calorie diet and increased Read more

Novo Nordisk signs pharma deal for diabetes drug

Zosano Pharma has entered into a pharma deal with Novo Nordisk to develop a new transdermal presentation of semaglutide. Semaglutide is an investigational proprietary human GLP-1 (Glucagon-Like Peptid...

Novo Nordisk Launches NovoFine Plus Needle

Novo Nordisk is now launching NovoFine Plus 32G 4mm, an ultra-thin, ultra-short universal pen needle that aims to make injections more comfortable for patients with diabetes.Re

BRIEF-Novo Nordisk confirms stock split Jan 2

COPENHAGEN, Dec 10 (Reuters) - Danish pharmaceutical company Novo Nordisk said in a statement on Tuesday:

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 24 March 2014

Bagsvaerd, Denmark, March 25, 2014 (GLOBE NEWSWIRE) -- In accordance with Section 28a of the Danish Securities Trading Act, the company's board members and executives have given Novo Nordisk power of...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

NOVOLIN N Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Physicians Total Care, Inc.]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

R HUMAN Novolin R Regular, Human Insulin Injection (recombinant DNA origin) USP 100 units/mL

PubMed Articles [173 Associated PubMed Articles listed on BioPortfolio]

Response to Hitman. Insulin degludec: a new insulin for today?

It is only natural that people with diabetes, their relatives and their physicians look for genuine therapeutic advance [1]. However, the development and marketing of a novel insulin analogue such as...

De novo Propionibacterium acnes Meningitis in a Patient with Metastatic Melanoma.

Propionibacterium acnes is a known cause of post-neurosurgical meningitis; however, it is rarely implicated in de novo meningitis. Herein we report a case of a 49 year-old male with de novo P. acnes m...

Cobalamin deficiency triggering de novo status epilepticus.

Cobalamin deficiency is included in the spectrum of very uncommon underlying causes of status epilepticus (SE) and the literature contains very few such cases. We herein report a case of unusual prese...

The clinical impact of switching attention deficit hyperactivity disorder patients from OROS(®)-MPH to Novo-MPH ER-C(®): A paediatric practice review.

In Canada, novo-methylphenidate extended-release capsules (Novo-MPH ER-C, Novopharm Limited, Canada) was approved as being bioequivalent to a current first-line treatment for attention deficit hyperac...

Exploring Genome Characteristics and Sequence Quality Without a Reference.

The de novo assembly of large, complex genomes is a significant challenge with currently available DNA sequencing technology. While many de novo assembly software packages are available, comparatively...

Clinical Trials [204 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.multiple daily injections, 3.anti-hyperglycemi...

Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia

The aim of this study is to test the safety and efficacy of a new algorithm for intensive s.c. insulin injection in medical emergency patients with hyperglycaemia (plasma glucose concentra...

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

This trial is conducted in Europe. This trial aims to ensure that there is no substantial clinically relevant difference between the two Novo Nordisk needles NovoFine® 6 x 0.30 mm and Nov...

Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects

This trial is conducted in Europe. The aim of this clinical trial is to compare the metabolism of a blood-clotting drug (recombinant Factor XIII) produced by two different manufacturers (N...

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

The study will enroll patients with angiographically significant coronary de novo lesions. Subjects will be randomized 1:1 and treated with a Lutonix catheter either before or after bare-m...

Companies [46 Associated Companies listed on BioPortfolio]

Novo A/S

Novo A/S is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S is a private limited liability company and the majority shareholder in the publicly listed...

Novo Nordisk, Inc.

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy...

Novo Nordisk A/S

Novo A/S, the holding company of the Novo Group, is fully owned by the Novo Nordisk Foundation and was established to manage the Foundation's funds and to invest actively in other companies. What make...

Novo Nordisk

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area...

Novo Nordisk Inc.

More Information about "Novo Nordisk, Inc." on BioPortfolio

We have published hundreds of Novo Nordisk, Inc. news stories on BioPortfolio along with dozens of Novo Nordisk, Inc. Clinical Trials and PubMed Articles about Novo Nordisk, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novo Nordisk, Inc. Companies in our database. You can also find out about relevant Novo Nordisk, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement